DE69630918D1 - Matrix für Iontophorese - Google Patents

Matrix für Iontophorese

Info

Publication number
DE69630918D1
DE69630918D1 DE69630918T DE69630918T DE69630918D1 DE 69630918 D1 DE69630918 D1 DE 69630918D1 DE 69630918 T DE69630918 T DE 69630918T DE 69630918 T DE69630918 T DE 69630918T DE 69630918 D1 DE69630918 D1 DE 69630918D1
Authority
DE
Germany
Prior art keywords
drug
humectant
weight
iontophoresis
proline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69630918T
Other languages
English (en)
Other versions
DE69630918T2 (de
Inventor
Yasuyuki Suzuki
Katsumi Iga
Yukihiro Matsumoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Publication of DE69630918D1 publication Critical patent/DE69630918D1/de
Application granted granted Critical
Publication of DE69630918T2 publication Critical patent/DE69630918T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DE69630918T 1995-06-09 1996-06-04 Matrix für Iontophorese Expired - Fee Related DE69630918T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP14298395 1995-06-09
JP14298395 1995-06-09
JP20190295 1995-08-08
JP20190295 1995-08-08

Publications (2)

Publication Number Publication Date
DE69630918D1 true DE69630918D1 (de) 2004-01-15
DE69630918T2 DE69630918T2 (de) 2004-10-28

Family

ID=26474826

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69630918T Expired - Fee Related DE69630918T2 (de) 1995-06-09 1996-06-04 Matrix für Iontophorese

Country Status (5)

Country Link
US (2) US5993848A (de)
EP (1) EP0747092B1 (de)
AT (1) ATE255450T1 (de)
CA (1) CA2178445A1 (de)
DE (1) DE69630918T2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5908400A (en) * 1996-06-20 1999-06-01 Hisamitsu Pharmaceutical Co., Inc. Device structure for iontophoresis
CA2208332A1 (en) * 1996-06-20 1997-12-20 Hisamitsu Pharmaceuticals Co., Inc. Drug administration composition for iontophoresis
EP0922467A3 (de) 1997-12-12 2000-05-24 Takeda Chemical Industries, Ltd. Iontophoretische Verabreichung von Medikamenten
JP4154017B2 (ja) * 1997-12-30 2008-09-24 久光製薬株式会社 イオントフォレーシス装置および薬物ユニット
JP4154016B2 (ja) * 1997-12-30 2008-09-24 久光製薬株式会社 イオントフォレーシス装置およびその組み立て方法
US6322550B2 (en) 1998-04-14 2001-11-27 Hisamitsu Pharmaceutical Co., Inc. Method for transdermal administration of GP IIb/IIIa antagonist
EP1222932B1 (de) 1999-10-14 2007-02-21 Pola Chemical Industries Inc. Zusammensetzungen für die elektroporation
WO2001026687A1 (fr) * 1999-10-14 2001-04-19 Pola Chemical Industries Inc. Compositions d'electroporation
AU2001277908A1 (en) * 2000-07-18 2002-01-30 Cornell Research Foundation Inc. Medicinal uses of mu-opioid receptor agonists
US6801804B2 (en) 2002-05-03 2004-10-05 Aciont, Inc. Device and method for monitoring and controlling electrical resistance at a tissue site undergoing iontophoresis
US7099713B2 (en) 2002-06-28 2006-08-29 Battelle Memorial Institute Skin conduction and transport systems
DK2656854T3 (en) * 2003-02-04 2015-07-06 Cornell Res Foundation Inc Applications of an aromatic-cationic peptide
BRPI0409911A (pt) 2003-05-01 2006-04-25 Cornell Res Foundation Inc método para liberar uma molécula em uma célula, e, complexo carreador
CA2851972C (en) * 2004-01-23 2015-06-23 Cornell Research Foundation, Inc. Methods for reducing oxidative damage
JP4615929B2 (ja) * 2004-08-11 2011-01-19 久光製薬株式会社 イオントフォレーシス装置
DE102005024040A1 (de) * 2005-05-25 2006-12-14 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Kosmetisches oder therapeutisches Kombinationspräparat mit Theanin
WO2006131931A2 (en) * 2005-06-10 2006-12-14 Transpharma Medical, Ltd. Patch for transdermal drug delivery
EP3725324A1 (de) * 2005-09-16 2020-10-21 Cornell Research Foundation, Inc. Aromatisch-kationisches peptid zur verwendung in einem verfahren zur reduzierung der cd36-expression
CA2696227A1 (en) * 2007-10-17 2009-04-23 Transpharma Medical Ltd. Dissolution rate verification
JP5508272B2 (ja) * 2007-10-29 2014-05-28 トランスファーマ メディカル リミテッド 垂直的なパッチ乾燥
SI2252312T1 (sl) 2008-02-07 2014-08-29 Cornell University, Postopki za preprečevanje ali zdravljenje insulinske rezistence
WO2009108695A2 (en) 2008-02-26 2009-09-03 Cornell University Methods for prevention and treatment of acute renal injury
CA2727015A1 (en) * 2008-06-04 2009-12-10 Coda Therapeutics, Inc. Treatment of pain with gap junction modulation compounds
US20100331265A1 (en) 2009-03-20 2010-12-30 Tompkins Ronald G Methods for the prevention and treatment of burn injuries and secondary complications
HUE029550T2 (en) * 2009-08-12 2017-03-28 Univ Cornell Methods of preventing or treating metabolic syndrome
PT2470191E (pt) 2009-08-24 2014-06-12 Stealth Peptides Int Inc Métodos e composições para prevenção ou tratamento de doenças oftálmicas
CN102711785A (zh) * 2009-10-05 2012-10-03 康奈尔大学 预防或治疗心力衰竭的方法
CN103918096B (zh) 2011-10-28 2018-09-28 印度马德拉斯理工学院 压电器件及其制备和使用方法
CN104736709A (zh) 2012-03-27 2015-06-24 科达治疗公司 基于钙粘蛋白调节的组合物和治疗
EP2849774A4 (de) 2012-05-18 2015-11-25 Otago Innovation Ltd Kombinationsbehandlungen und zusammensetzungen zur wundheilung

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4593053A (en) * 1984-12-07 1986-06-03 Medtronic, Inc. Hydrophilic pressure sensitive biomedical adhesive composition
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US5250022A (en) * 1990-09-25 1993-10-05 Rutgers, The State University Of New Jersey Iontotherapeutic devices, reservoir electrode devices therefore, process and unit dose
US5612347A (en) * 1988-03-28 1997-03-18 Janssen Pharmaceutica N.V. Agents for preserving or restoring the soundness of the skin
CA2026885C (en) * 1989-02-06 1998-12-01 Keiichirou Okabe Interface for iontophorese
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
US5158537A (en) * 1990-10-29 1992-10-27 Alza Corporation Iontophoretic delivery device and method of hydrating same
AU3070892A (en) * 1991-11-12 1993-06-15 Nepera, Inc. Adhesive hydrogels having extended use lives and process for the preparation of same
ATE169826T1 (de) * 1992-01-21 1998-09-15 Macrochem Corp Iontophoretische verbesserte verabreichung von medikamenten
AU677206B2 (en) * 1992-06-11 1997-04-17 Theratech, Inc. The use of glycerin in moderating transdermal drug delivery
JPH0616538A (ja) * 1992-07-03 1994-01-25 Japan Tobacco Inc イオントフォレーゼのための薬物吸収用液組成物
JPH0616535A (ja) * 1992-07-03 1994-01-25 Japan Tobacco Inc イオントフォレーゼ用インターフェイス
ES2180546T3 (es) * 1992-07-23 2003-02-16 Hisamitsu Pharmaceutical Co Composicion basica administrable percutaneamente y composicion de farmaco preparada a partir de ella.
EP0643981B1 (de) * 1993-09-22 2002-01-09 Hisamitsu Pharmaceutical Co., Inc. Iontophoresematrix
US5472958A (en) * 1994-08-29 1995-12-05 Abbott Laboratories 2-((nitro)phenoxymethyl) heterocyclic compounds that enhance cognitive function

Also Published As

Publication number Publication date
US5993848A (en) 1999-11-30
CA2178445A1 (en) 1996-12-10
US6248349B1 (en) 2001-06-19
EP0747092A2 (de) 1996-12-11
DE69630918T2 (de) 2004-10-28
EP0747092B1 (de) 2003-12-03
ATE255450T1 (de) 2003-12-15
EP0747092A3 (de) 1998-04-08

Similar Documents

Publication Publication Date Title
DE69630918D1 (de) Matrix für Iontophorese
ES2526707T3 (es) Purificación y estabilización de péptidos y proteínas en agentes farmacéuticos
DE69329367D1 (de) Wachstumshormon-enthaltendeproteinformulierung
ATE204467T1 (de) Orale darreichungsform
KR880009632A (ko) 폴리펩티드의 전해식 경피투여
CA2275890A1 (en) Stable liquid interferon formulations
DE69831785D1 (de) Tulobuterol enthaltendes Präparat für perkutane Absorption
DE69417397T2 (de) Lösung, die igf-1 enthält
US6399566B1 (en) Topical preparation for introducing insulin in living organisms
ATE226832T1 (de) Mittel zur arzneistoffverabreichung durch iontophorese
OA12322A (en) Topical pharmaceutical preparation.
TH19245A (th) วิธีป้องกันการสลายของโปรตีนซี
CA2153787A1 (en) Solution containing igf-1
TH25313A (th) องค์ประกอบทางเภสัชที่ออกฤทธิ์ผ่านทางผิวหนังที่มีกรด 5-แอมิโนเลฟวูลินิกประกอบอยู่
TH14574EX (th) สารผสมทางเภสัชกรรม

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee